| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 169.58M | — |
| Operating expense | — | — |
| Net income | -34.80M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TVTX returned +266.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +72.0% |
| 1 year | +266.7% |
| 5 years | +201.0% |
| 10 years | +310.2% |
| All-time high | $65.71 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TVTX would be worth today ›No. Travere Therapeutics, Inc. has not paid a dividend in the past 12 months.
Travere Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol TVTX.
Travere Therapeutics, Inc. is part of the Healthcare sector.
Travere Therapeutics, Inc. has a market cap of 6.19B USD, based on the latest quote.
Travere Therapeutics, Inc. is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
